James Valentine

517 total citations
7 papers, 315 citations indexed

About

James Valentine is a scholar working on Genetics, Economics and Econometrics and Psychiatry and Mental health. According to data from OpenAlex, James Valentine has authored 7 papers receiving a total of 315 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Genetics, 2 papers in Economics and Econometrics and 2 papers in Psychiatry and Mental health. Recurrent topics in James Valentine's work include Genomics and Rare Diseases (3 papers), Health Systems, Economic Evaluations, Quality of Life (2 papers) and Intellectual Property and Patents (1 paper). James Valentine is often cited by papers focused on Genomics and Rare Diseases (3 papers), Health Systems, Economic Evaluations, Quality of Life (2 papers) and Intellectual Property and Patents (1 paper). James Valentine collaborates with scholars based in United States, Netherlands and Switzerland. James Valentine's co-authors include Kristina Larsson, Robert A. Preti, Marco Prunotto, Benjamin Vandendriessche, Philip J. Brooks, Kay E. Davies, Tudor I. Oprea, Katherine I. Miller Needleman, Stephen C. Groft and Erik Tambuyzer and has published in prestigious journals such as Nature Reviews Drug Discovery, Orphanet Journal of Rare Diseases and Advances in Therapy.

In The Last Decade

James Valentine

7 papers receiving 310 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
James Valentine United States 4 129 96 74 42 31 7 315
Erik Tambuyzer Belgium 5 151 1.2× 145 1.5× 112 1.5× 47 1.1× 35 1.1× 12 431
Tan T. Nguyen United States 6 67 0.5× 116 1.2× 63 0.9× 28 0.7× 43 1.4× 7 320
Katherine I. Miller Needleman United States 5 119 0.9× 88 0.9× 54 0.7× 37 0.9× 20 0.6× 8 260
Anneliene Hechtelt Jonker France 13 184 1.4× 256 2.7× 83 1.1× 41 1.0× 50 1.6× 28 515
Lynn M. Neilson United States 10 173 1.3× 74 0.8× 20 0.3× 20 0.5× 9 0.3× 25 389
Ryan Noss United States 10 88 0.7× 182 1.9× 13 0.2× 9 0.2× 20 0.6× 17 339
Gemma A. Foulds United Kingdom 14 144 1.1× 36 0.4× 10 0.1× 20 0.5× 50 1.6× 28 432
ACMG Board of Directors 6 60 0.5× 208 2.2× 19 0.3× 9 0.2× 38 1.2× 10 299
Chachrit Khunsriraksakul United States 10 181 1.4× 62 0.6× 12 0.2× 8 0.2× 23 0.7× 21 333
Nuala Moran United Kingdom 11 124 1.0× 41 0.4× 35 0.5× 5 0.1× 57 1.8× 50 347

Countries citing papers authored by James Valentine

Since Specialization
Citations

This map shows the geographic impact of James Valentine's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James Valentine with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James Valentine more than expected).

Fields of papers citing papers by James Valentine

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James Valentine. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James Valentine. The network helps show where James Valentine may publish in the future.

Co-authorship network of co-authors of James Valentine

This figure shows the co-authorship network connecting the top 25 collaborators of James Valentine. A scholar is included among the top collaborators of James Valentine based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James Valentine. James Valentine is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Schwartz, Carolyn E., et al.. (2023). Toward patient-centered treatment goals for duchenne muscular dystrophy: insights from the “Your Voice” study. Orphanet Journal of Rare Diseases. 18(1). 90–90. 3 indexed citations
2.
Brandt, Teresa, Angela Taylor, James Valentine, et al.. (2021). Symptoms and Treatment Needs of People with Dementia-Related Psychosis: A Mixed-Methods Study of the Patient Experience. Clinical Gerontologist. 45(3). 681–695. 2 indexed citations
3.
Tambuyzer, Erik, Benjamin Vandendriessche, Christopher P. Austin, et al.. (2020). Publisher Correction: Therapies for rare diseases: therapeutic modalities, progress and challenges ahead. Nature Reviews Drug Discovery. 19(4). 291–291. 3 indexed citations
4.
Valentine, James, et al.. (2019). The Case for the Use of Patient and Caregiver Perception of Change Assessments in Rare Disease Clinical Trials: A Methodologic Overview. Advances in Therapy. 36(5). 997–1010. 19 indexed citations
5.
Tambuyzer, Erik, Benjamin Vandendriessche, Christopher P. Austin, et al.. (2019). Therapies for rare diseases: therapeutic modalities, progress and challenges ahead. Nature Reviews Drug Discovery. 19(2). 93–111. 222 indexed citations
6.
Bloom, Diane, Matthew Harker, Sharon Hesterlee, et al.. (2017). The Rules of Engagement: CTTI Recommendations for Successful Collaborations Between Sponsors and Patient Groups Around Clinical Trials. Therapeutic Innovation & Regulatory Science. 52(2). 206–213. 36 indexed citations
7.
Valentine, James, et al.. (2015). Quantum of Effectiveness Evidence in FDA’s Approval of Orphan Drugs: Update, July 2010 to June 2014. Therapeutic Innovation & Regulatory Science. 49(5). 680–697. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026